Home > Healthcare & Medical Devices > Sleep Disorder Market

Sleep Disorder Market - By Disorder (Sleep Apnea, Restless Legs Syndrome, Insomnia, Narcolepsy), By Product (Diagnostics, Therapeutics), By End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals) & Global Forecast, 2023-2032

  • Report ID: GMI5172
  • Published Date: Mar 2023
  • Report Format: PDF

Sleep Disorder Market Size

Sleep Disorder Market size was worth over USD 22.5 billion in 2022 and is poised to depict significant growth at more than 12% CAGR from 2023 to 2032 owing to the rising prevalence of sleep disorders worldwide.

Sleep Disorder Market Overview

To understand key trends  
Download Free Sample

The upsurge in the number of patients experiencing sleep apnea and other co-morbidities is among the major factors affecting the demand for therapeutic and diagnostic equipment due to their dependability and ergonomic design that assist patients in performing an easy sleep test. The American Sleep Association estimates that between 50 and 70 million individuals in the U.S. suffer from sleep disorders. These illnesses commonly coexist with issues such as anxiety, depression, and posttraumatic stress disorder (PTSD). This high incidence rate is also associated with the rising adoption of a sedentary lifestyle, which is expected to drive market size.


Stringent regulatory framework to limit industry landscape

The FDA has highly stringent regulatory compliances and lengthy approval procedures that are impeding the expansion of the sleep disorder market. The FDA classifies sleep diagnosis and therapy devices as Class II due to the possible risks they pose. These devices often require the highest level of scrutiny and a comprehensive set of preclinical and clinical assessments via pre-market authorization. The stringent regulatory framework related to sleep disorder treatment devices is estimated to slow down the growth of the industry. 

Sleep Disorder Market Analysis

Sleep Disorder Market Size

To understand key market trends  
Download Free Sample

By disorder, the sleep disorder market from the sleep apnea segment is expected to expand at over 12% CAGR through 2032. The American Academy of Sleep Medicine (AASM) estimates that more than 25 million individuals in the U.S. have obstructive sleep apnea. The rapidly aging population has led to the increasing prevalence of sleep apnea illnesses. According to the United States Census Bureau, there are more than 56 million individuals aged 65 and above in the country, accounting for around 16.9% of the total population. Improving living standards and availability of superior healthcare services have enhanced life expectancy rates in many countries, which is estimated to contribute to business progression.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for sleep disorder exceeded USD 22.5 billion in 2022 and is set to grow at over 12% CAGR through 2032, driven by the rising prevalence of sleep disorders worldwide.

Therapeutics segment generated more than USD 8.5 billion in 2022 and is expected to grow significantly through 2032, owing to the growing popularity of oral appliance therapy.

North American sleep disorder market is poised to exhibit over 11.5% CAGR through 2032 attributed to the high prevalence of sleep disorders.

Fisher & Paykel Healthcare, Koninklijke Philips N.V., Invacare Corporation, Teleflex Inc., ResMed Inc., and Natus Medical Inc., among others, are the major player engaged in the sleep disorder industry.

Sleep Disorder Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 20
  • Tables & Figures: 629
  • Countries covered: 29
  • Pages: 250
 Download Free Sample